p>Qualifications: • MD or PhD in Immunology, Hematology/Oncology; Cancer Biology, Bioengineering, or related field • 2-5 years post-degree research experience in immune-effector cell therapy or closely related area • Hands-on expertise in cell engineering (viral/non-viral delivery; CRISPR or equivalent), primary T/NK cell culture, and functional immunology assays • Previous extramural funding: i.e., K award, R21, DOD • Demonstrated track record of impactful publications and team-based science.
About The University of Kansas Hospital:
Recognized as one of the top hospitals in the United States by U.S. News & World Report, The University of Kansas Hospital is a 1045-bed academic medical center and Level 1 trauma center, with a mission to lead in the discovery of new knowledge, deliver outstanding patient care in this region and beyond, and educate the healthcare professionals of tomorrow.